Table 1.
Baseline Characteristics.
| Variable | Results (n=54) Mean (%) |
|---|---|
| Age (years) | |
| n | 54 |
| Mean | 68 |
| STD | 11.2 |
|
| |
| Gender | |
| Female | 16(30%) |
| Male | 38(70%) |
|
| |
| Race | |
| Caucasian | 41 (76%) |
| African American | 3 (5%) |
| Other | 10(19%) |
|
| |
| Comorbidities | |
| Smoking | 28(52%) |
| Alcohol Use | 11(20%) |
| History of Pancreatitis | 7(13%) |
| Diabetes | 19(35%) |
|
| |
| Tumor Characteristics | |
| ECOG Score 0-1 | 15(28%) |
| Elevated CA-19 (>34) | 19(36%) |
| Biliary Stenting (pre-OP) | 39(74%) |
| Tumor Histology | 28(44%) |
| Ductal Adenocarcinoma | 38(72%) |
| Adenocarcinoma not otherwise specified | 8(15%) |
| Mucinous Adenocarcinoma | 4(9%) |
|
| |
| Tumor Grade | |
| G1: Well Differentiated | 5(9%) |
| G3: Moderately Differentiated | 33(61%) |
| Unknown | 16(29%) |
|
| |
| Tumor stages(TNM) | |
| Stage I | 13(24%) |
| Stage II | 9(20%) |
| Stage III | 25(44%) |
| Stage IV | 7(12%) |